Oncology Education | Videos
Congratulations to Dr. Prasanna Alluri,... - UT Southwestern Radiation Oncology | Facebook
Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology
PLOS ONE: Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
OncologyEducation on Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiEBcN… https://t.co/3aAVqpqbMy"
Stemmer med våre salgstall
Transnational cancer research lab | Felsenstein Medical Research Center
Stemmer med våre salgstall
Transnational cancer research lab | Felsenstein Medical Research Center
Salomon M Stemmer | Rabin Medical Center | Israel
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
The value of source data verification in a cancer clinical trial
GRAPES: A CANCER CELL INHIBITOR?
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
Cetuximab intensifies cisplatin-induced testicular toxicity - ppt download
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Can-Fite to Treat Advanced Liver Cancer Patients with Namodenoson Under Compassionate Use Setting in Israel | Business Wire
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
GRAPES: A CANCER CELL INHIBITOR?
Ribociclib Improves Progression-Free Survival for Women with Metastatic Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
